Trade Summary

2 days ago, Bluestone Jeffrey, serving as Dir at GILEAD SCIENCES, INC. (GILD), sold 5,000 shares at $145.02 per share, for a total transaction value of $725,077.68. Following this transaction, Bluestone Jeffrey now holds 10,066 shares of GILD.

This sale represents a 33.19% decrease in Bluestone Jeffrey's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, August 20, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 21, 2026 at 7:22 PM ET, 1 day after the trade was made.

GILEAD SCIENCES, INC. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - GENERAL industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.